Article
Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study.
BMC infectious diseases - 21 Dec 2014
Velentzis Louiza S, Sitas Freddy, O'Connell Dianne L, Darlington-Brown Jessica, Egger Sam, Sinha Rohit, Banks Emily, Frazer Ian H, Canfell Karen
Abstract excerpt
BACKGROUND: Australia commenced human papillomavirus (HPV) vaccination in 2007, with a two-year catch-up to the age of 26; catch-up cohorts are thus now entering their thirties. Plans for monitoring vaccine impact involve pre- and post-vaccination assessment of cervical HPV DNA in the general population and in high grade abnormalities. Although HPV serology is less sensitive than DNA genotyping, it assesses...
Topics
Join the communities discussing this publication.